Inogen Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Kevin R. Smith

Chief executive officer

US$2.4m

Total compensation

CEO salary percentage4.4%
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenure2.7yrs

Recent management updates

Recent updates

Inogen: Upside Seems Limited After Big Move Up

Sep 24

Inogen, Inc.'s (NASDAQ:INGN) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Jul 16
Inogen, Inc.'s (NASDAQ:INGN) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Inogen: Improving, But Still Struggling For Air

Jul 01

Inogen, Inc. (NASDAQ:INGN) Stock Catapults 28% Though Its Price And Business Still Lag The Industry

May 22
Inogen, Inc. (NASDAQ:INGN) Stock Catapults 28% Though Its Price And Business Still Lag The Industry

Inogen: New Management And A Major Competitor Exit Offer Some New Opportunities

Apr 13

Inogen, Inc. (NASDAQ:INGN) Just Reported, And Analysts Assigned A US$6.50 Price Target

Mar 01
Inogen, Inc. (NASDAQ:INGN) Just Reported, And Analysts Assigned A US$6.50 Price Target

Inogen, Inc. (NASDAQ:INGN) Held Back By Insufficient Growth Even After Shares Climb 25%

Feb 01
Inogen, Inc. (NASDAQ:INGN) Held Back By Insufficient Growth Even After Shares Climb 25%

Is Inogen (NASDAQ:INGN) In A Good Position To Deliver On Growth Plans?

Oct 06
Is Inogen (NASDAQ:INGN) In A Good Position To Deliver On Growth Plans?

Inogen (NASDAQ:INGN) Is In A Strong Position To Grow Its Business

Jun 21
Inogen (NASDAQ:INGN) Is In A Strong Position To Grow Its Business

Is Inogen, Inc. (NASDAQ:INGN) Worth US$13.3 Based On Its Intrinsic Value?

Mar 14
Is Inogen, Inc. (NASDAQ:INGN) Worth US$13.3 Based On Its Intrinsic Value?

Companies Like Inogen (NASDAQ:INGN) Can Afford To Invest In Growth

Oct 27
Companies Like Inogen (NASDAQ:INGN) Can Afford To Invest In Growth

Inogen, Inc.'s (NASDAQ:INGN) Intrinsic Value Is Potentially 64% Above Its Share Price

Sep 20
Inogen, Inc.'s (NASDAQ:INGN) Intrinsic Value Is Potentially 64% Above Its Share Price

Inogen: Structural, Supply Chain Headwinds Remain

Sep 13

Inogen Non-GAAP EPS of -$0.02 beats by $0.31, revenue of $103.38M beats by $2.74M

Aug 04

Inogen: Seasonal FCF, Tightening Margins, Supply Chain Headwinds

Jun 14

At US$35.28, Is It Time To Put Inogen, Inc. (NASDAQ:INGN) On Your Watch List?

Apr 03
At US$35.28, Is It Time To Put Inogen, Inc. (NASDAQ:INGN) On Your Watch List?

Hammered By Supply Issues, Inogen Could Be A 2023 Comeback Story

Mar 31

Is There An Opportunity With Inogen, Inc.'s (NASDAQ:INGN) 28% Undervaluation?

Mar 09
Is There An Opportunity With Inogen, Inc.'s (NASDAQ:INGN) 28% Undervaluation?

CEO Compensation Analysis

How has Kevin R. Smith's remuneration changed compared to Inogen's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$53m

Jun 30 2024n/an/a

-US$92m

Mar 31 2024n/an/a

-US$97m

Dec 31 2023US$2mUS$108k

-US$102m

Compensation vs Market: Kevin R.'s total compensation ($USD2.45M) is above average for companies of similar size in the US market ($USD1.46M).

Compensation vs Earnings: Insufficient data to compare Kevin R.'s compensation with company performance.


CEO

Kevin R. Smith (53 yo)

less than a year

Tenure

US$2,448,754

Compensation

Mr. Kevin R. M. Smith serves as President, Chief Executive Officer and Director at Inogen Inc. since November 13, 2023. He served as Director at OncoSec Medical Incorporated since February 7, 2020 until Ju...


Leadership Team

NamePositionTenureCompensationOwnership
Kevin R. Smith
Presidentless than a yearUS$2.45mno data
Michael Bourque
Executive VPless than a yearno datano data
Philip Corrin
Senior Vice President of Operations & Supply Chain1.8yrsno datano data
Kevin Smith
General Counsel & Executive VP of Business Developmentless than a yearno datano data
Jennifer Boyer
Executive VP & Chief Human Resources Officer2.5yrsno datano data
Grgoire Ramade
Executive VP & Chief Commercial Officerless than a yearno datano data
Krishna Jhaveri
Chief Medical Officerless than a yearno datano data
Paul Andreassi
Senior Vice President of Quality & Regulatory Affairsless than a yearno datano data
Adrien Mithalal
Senior Vice President of Research & Developmentless than a yearno datano data

0.8yrs

Average Tenure

54yo

Average Age

Experienced Management: INGN's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Kevin R. Smith
Presidentless than a yearUS$2.45mno data
Richard Casaburi
Member of Advisory Boardno datano datano data
Jeffrey Kupperman
Member of Advisory Boardno datano datano data
Paul Selecky
Member of Advisory Boardno datano datano data
Mary Ladone
Independent Director2.7yrsUS$242.50k0.10%
$ 228.9k
Kevin King
Independent Director2.7yrsUS$250.00k0.10%
$ 228.9k
Neil MacIntyre
Member of Advisory Boardno datano datano data
Elizabeth Mora
Independent Board Chairperson3.5yrsUS$315.00k0.11%
$ 250.4k
Robert Chatburn
Member of Advisory Boardno datano datano data
Thomas West
Independent Director1.6yrsUS$266.24k0.079%
$ 176.4k
Heather Rider
Independent Director10.3yrsUS$242.50k0.16%
$ 353.8k
Glenn Boehnlein
Independent Director2.7yrsUS$250.00k0.10%
$ 228.9k

2.7yrs

Average Tenure

62yo

Average Age

Experienced Board: INGN's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.